FDA Peptide Reclassification 2026: What It Means for Providers Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law Major peptide regulatory news this week. The FDA announced on April 15 that it will remove 12 peptides from Category 2 of the 503A bulk drug substances list after seven calendar days. When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of